RON HOOGEVEEN to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications RON HOOGEVEEN has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0.132
-
Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models. HIV Med. 2016 Apr; 17(4):289-97.
Score: 0.109
-
Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients. Metabolism. 2013 Jul; 62(7):1014-20.
Score: 0.023